These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6296358)

  • 21. Discriminative stimulus properties of nalorphine in the rhesus monkeys.
    Tang AH; Code RA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):563-9. PubMed ID: 6317838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential tolerance and cross-tolerance to chronic treatment with mu and kappa opioid agonists in the rat.
    Young GA; Khazan N
    NIDA Res Monogr; 1984 Mar; 49():121-7. PubMed ID: 6090915
    [No Abstract]   [Full Text] [Related]  

  • 23. The antiproliferative effect of opioid receptor agonists on the T47D human breast cancer cell line, is partially mediated through opioid receptors.
    Hatzoglou A; Bakogeorgou E; Castanas E
    Eur J Pharmacol; 1996 Jan; 296(2):199-207. PubMed ID: 8838457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Narcotic discrimination in pigeons.
    Herling S; Coale EH; Valentino RJ; Hein DW; Woods JH
    J Pharmacol Exp Ther; 1980 Jul; 214(1):139-46. PubMed ID: 6993656
    [No Abstract]   [Full Text] [Related]  

  • 25. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
    Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
    Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of endogenous opioid systems in social behavior of individually-housed mice.
    Puglisi-Allegra S; Mele A; Cabib S
    Prog Clin Biol Res; 1984; 167():209-25. PubMed ID: 6095318
    [No Abstract]   [Full Text] [Related]  

  • 27. Recent studies on opioid receptors: heterogeneity and purification.
    Simon EJ
    Ann N Y Acad Sci; 1986; 463():31-45. PubMed ID: 3013065
    [No Abstract]   [Full Text] [Related]  

  • 28. Involvement of delta 2 opioid receptors in acute dependence on morphine in mice.
    Miyamoto Y; Portoghese PS; Takemori AE
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1325-7. PubMed ID: 8389861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity.
    Portoghese PS; Nagase H; Lipkowski AW; Larson DL; Takemori AE
    J Med Chem; 1988 Apr; 31(4):836-41. PubMed ID: 2832604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional opiate receptor in mouse vas deferens: evidence for a complex interaction.
    Sánchez-Blázquez P; Garzón J; Lee NM
    J Pharmacol Exp Ther; 1983 Sep; 226(3):706-11. PubMed ID: 6310079
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of diabetes on the morphine-induced inhibition of gastrointestinal transit.
    Kamei J; Ohsawa M; Misawa M; Nagase H; Kasuya Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1995 Apr; 15(2):165-9. PubMed ID: 7796321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inverse agonist action of Leu-enkephalin at delta(2)-opioid receptors mediates spinal antianalgesia.
    Rady JJ; Holmes BB; Tseng LF; Fujimoto JM
    J Pharmacol Exp Ther; 2001 May; 297(2):582-9. PubMed ID: 11303046
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of opioid receptors in phencyclidine-induced enhancement of brain histamine turnover in mice.
    Itoh Y; Oishi R; Nishibori M; Saeki K
    Naunyn Schmiedebergs Arch Pharmacol; 1987 Mar; 335(3):285-9. PubMed ID: 2884577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased analgesic potency of morphine and increased brain opioid binding sites in the rat following chronic naltrexone treatment.
    Yoburn BC; Goodman RR; Cohen AH; Pasternak GW; Inturrisi CE
    Life Sci; 1985 Jun; 36(24):2325-32. PubMed ID: 2989632
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ketazocines and morphine: effects on gastrointestinal transit after central and peripheral administration.
    Porreca F; Cowan A; Raffa RB; Tallarida RJ
    Life Sci; 1983 Apr; 32(15):1785-90. PubMed ID: 6339861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the criteria for classifying opiate agonists in rats.
    Porreca F; Cowan A; Raffa RB; Tallarida RJ
    J Pharm Pharmacol; 1982 Aug; 34(8):525-6. PubMed ID: 6126567
    [No Abstract]   [Full Text] [Related]  

  • 37. Analeptic effect of opiate receptor agonists in rabbits.
    Yamawaki S; Carino MA; Horita A
    Neurosci Lett; 1985 Mar; 55(1):61-4. PubMed ID: 2859565
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quaternary narcotic antagonists' relative ability to prevent antinociception and gastrointestinal transit inhibition in morphine-treated rats as an index of peripheral selectivity.
    Bianchi G; Fiocchi R; Tavani A; Manara L
    Life Sci; 1982 May; 30(22):1875-83. PubMed ID: 7109826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The opioid-induced desensitization (tolerance) in neuroblastoma x glioma NG 108-15 hybrid cells: results from receptor uncoupling.
    Wüster M; Costa T
    NIDA Res Monogr; 1984; 54():136-45. PubMed ID: 6099870
    [No Abstract]   [Full Text] [Related]  

  • 40. [3H]ethylketocyclazocine binding to NCB-20 hybrid neurotumor cells.
    West RE; McLawhon RW; Dawson G; Miller RJ
    Mol Pharmacol; 1983 Mar; 23(2):486-92. PubMed ID: 6339880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.